Rubius Therapeutics Pink Sheet Forecast - Accumulation Distribution

RUBYDelisted Stock  USD 0.08  0.02  17.00%   
Rubius Pink Sheet Forecast is based on your current time horizon.
  
On January 4, 2023 Rubius Therapeutics had Accumulation Distribution of 153999.0. The accumulation distribution (A/D) indicator shows the degree to which Rubius Therapeutics is accumulated by the market over a given period. It uses the quote sensitivity to the highest or lowest daily price of Rubius Therapeutics to determine if accumulation or reduction is taking place in the market. This value is adjusted by Rubius Therapeutics trading volume to give more weight to distributions with higher volume over lower volume.
Check Rubius Therapeutics VolatilityBacktest Rubius TherapeuticsTrend Details  

Rubius Therapeutics Trading Date Momentum

On January 05 2023 Rubius Therapeutics was traded for  0.21  at the closing time. The top price for the day was 0.22  and the lowest listed price was  0.16 . The trading volume for the day was 2.4 M. The trading history from January 5, 2023 was a factor to the next trading day price jump. The trading delta at closing time against the next closing price was 31.25% . The trading delta at closing time against the current closing price is 18.75% .
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume
Compare Rubius Therapeutics to competition

Rubius Therapeutics Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Rubius Therapeutics pink sheet to make a market-neutral strategy. Peer analysis of Rubius Therapeutics could also be used in its relative valuation, which is a method of valuing Rubius Therapeutics by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

Rubius Therapeutics Market Strength Events

Market strength indicators help investors to evaluate how Rubius Therapeutics pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Rubius Therapeutics shares will generate the highest return on investment. By undertsting and applying Rubius Therapeutics pink sheet market strength indicators, traders can identify Rubius Therapeutics entry and exit signals to maximize returns.

Rubius Therapeutics Risk Indicators

The analysis of Rubius Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Rubius Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting rubius pink sheet prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.
You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.

Other Consideration for investing in Rubius Pink Sheet

If you are still planning to invest in Rubius Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Rubius Therapeutics' history and understand the potential risks before investing.
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years